ROGER J NICOSIA

Allopathic & Osteopathic Physicians|Family Medicine STUART, FL NPI 1548213697

General Payments — all program years on this page

$3,454.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 187
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $416.23 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $416.2322

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $432.0523
2019 $399.8923
2020 $323.3620
2021 $711.2838
2022 $668.2033
2023 $503.3128
2024 $416.2322

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086192008 Bayer Healthcare Pharmaceuticals Inc. $20.15 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097188420 Novo Nordisk Inc $17.88 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097420713 Novo Nordisk Inc $17.63 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104233585 AstraZeneca Pharmaceuticals LP $21.67 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104748581 AstraZeneca Pharmaceuticals LP $14.87 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105125585 ABBVIE INC. $22.74 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105125587 ABBVIE INC. $26.52 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105125589 ABBVIE INC. $24.42 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105125591 ABBVIE INC. $20.28 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105125593 ABBVIE INC. $0.82 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105125595 ABBVIE INC. $17.87 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105125597 ABBVIE INC. $20.04 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105549339 AstraZeneca Pharmaceuticals LP $21.48 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105656250 AstraZeneca Pharmaceuticals LP $22.95 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105752705 AstraZeneca Pharmaceuticals LP $18.47 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114810198 Exact Sciences Corporation $16.50 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116545246 GlaxoSmithKline, LLC. $13.41 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132095384 PFIZER INC. $19.84 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135363335 Lilly USA, LLC $27.21 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135400139 Lilly USA, LLC $23.07 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139291162 Astellas Pharma US Inc $13.56 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153332267 Dexcom, Inc. $14.85 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.